JP2004210715A5 - - Google Patents

Download PDF

Info

Publication number
JP2004210715A5
JP2004210715A5 JP2002382121A JP2002382121A JP2004210715A5 JP 2004210715 A5 JP2004210715 A5 JP 2004210715A5 JP 2002382121 A JP2002382121 A JP 2002382121A JP 2002382121 A JP2002382121 A JP 2002382121A JP 2004210715 A5 JP2004210715 A5 JP 2004210715A5
Authority
JP
Japan
Prior art keywords
osteoclast formation
formation inhibitor
sulfated glycosaminoglycan
inhibitor according
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002382121A
Other languages
English (en)
Japanese (ja)
Other versions
JP4567942B2 (ja
JP2004210715A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002382121A priority Critical patent/JP4567942B2/ja
Priority claimed from JP2002382121A external-priority patent/JP4567942B2/ja
Publication of JP2004210715A publication Critical patent/JP2004210715A/ja
Publication of JP2004210715A5 publication Critical patent/JP2004210715A5/ja
Application granted granted Critical
Publication of JP4567942B2 publication Critical patent/JP4567942B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002382121A 2002-12-27 2002-12-27 破骨細胞形成抑制剤 Expired - Fee Related JP4567942B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002382121A JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002382121A JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Publications (3)

Publication Number Publication Date
JP2004210715A JP2004210715A (ja) 2004-07-29
JP2004210715A5 true JP2004210715A5 (enExample) 2006-02-09
JP4567942B2 JP4567942B2 (ja) 2010-10-27

Family

ID=32817794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002382121A Expired - Fee Related JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Country Status (1)

Country Link
JP (1) JP4567942B2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401069D0 (sv) * 2004-04-26 2004-04-26 Anamar Medical Ab Use of Compounds for the Treatment of Diseases and Conditions
WO2006068146A1 (ja) * 2004-12-20 2006-06-29 Seikagaku Corporation 新規コンドロイチン硫酸画分
US20090012278A1 (en) 2005-03-14 2009-01-08 Seikagaku Corporation Promoter For Hard Tissue Formation
JP5051999B2 (ja) * 2005-11-17 2012-10-17 国立大学法人名古屋大学 炎症性骨・軟骨疾患の処置剤
JP2007224286A (ja) * 2006-01-25 2007-09-06 Tottori Univ 生体組織からの多糖類の取得方法
JP5099617B2 (ja) * 2006-03-16 2012-12-19 国立大学法人東京農工大学 歯周病予防・治療剤
JP5063940B2 (ja) * 2006-06-20 2012-10-31 生化学工業株式会社 コンドロイチン硫酸・鉄コロイド製剤及びその製造方法
WO2008102568A1 (ja) * 2007-02-22 2008-08-28 Pg Research Co., Ltd. 骨軟骨形成促進剤
SG181615A1 (en) * 2009-12-09 2012-07-30 Agency Science Tech & Res Glycosaminoglycan mixtures
JP6205350B2 (ja) * 2011-05-12 2017-09-27 ニョシス ソシエタ ペル アチオニ 同じ多糖鎖の４位または６位でバイオテクノロジー的に硫酸化されたコンドロイチン硫酸、およびその調整方法
CN105924544B (zh) * 2016-05-16 2018-03-09 山东大学 一种高硫酸化硫酸软骨素及其制备方法与应用
JP7673944B2 (ja) * 2020-12-23 2025-05-09 国立大学法人東海国立大学機構 破骨細胞増殖性疾患の予防又は治療剤
WO2024225380A1 (ja) * 2023-04-25 2024-10-31 国立大学法人東北大学 骨吸収の抑制剤

Similar Documents

Publication Publication Date Title
JP2004210715A5 (enExample)
BR0315149A (pt) Misturas de polissacarìdeos derivados de heparina, sua preparação e as composições farmacêuticas que as contêm
Draget et al. Ionic and acid gel formation of epimerised alginates; the effect of AlgE4
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
BRPI0413728A (pt) muteìnas de lipocalina da lágrima
JP2011513034A5 (enExample)
WO2002023190A8 (en) Methods and products related to low molecular weight heparin
MX2009001203A (es) Muteinas de lipocalina lacrimosa y metodos para obtener las mismas.
Nishi et al. Enantiomer separation by capillary electrophoresis utilizing noncyclic mono-, oligo-and polysaccharides as chiral selectors
WO2004029095A3 (en) Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof
Linhardt et al. Low molecular weight dermatan sulfate as an antithrombotic agent structure-activity relationship studies
HRP20000008B1 (hr) Sastav mineralne vune sa svojstvom biorazgradivosti
EP1659143A4 (en) HYDROGEL SENSITIVE AT TEMPERATURE
DK1366082T3 (da) Höjsulfaterede derivater af K5-polysaccharid og deres fremstilling
CA2529441A1 (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
ATE236933T1 (de) Oligosaccharidemischungen mit antithrombotischer wirkung
IL165808A0 (en) Low molecular weight k5-n,o-oversulfated polysaccharide process for the preparation thereof and pharmaceutical compositions containing the same
EP3082869B1 (en) Combination of glycosaminoglycans and cyclodextrins
UA89356C2 (ru) Смесь олигосахаридов, которые являются производными гепаринина, способ ее получения и фармацевтическая композиция, которая их содержит
ATE388169T1 (de) Niedermolekulare polysaccharide mit antithrombotischer wirkung
TW200704403A (en) Dilution resistant viscoelastic compositions
JP2005047929A5 (enExample)
TW200745154A (en) Oligosaccharides derived from fucoidan
JP2007126453A5 (enExample)
Maaroufi et al. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation